Mercury Poisoning
3
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
EmeraMedIreland - Dublin
2 programs1
1
NBMI Treatment in Patients With Mercury ToxicityPhase 2/31 trial
EmeramidePhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
EmeraMedNBMI Treatment in Patients With Mercury Toxicity
EmeraMedEmeramide
Clinical Trials (2)
Total enrollment: 152 patients across 2 trials
NBMI Treatment in Patients With Mercury Toxicity
Start: Nov 2023Est. completion: Nov 2024116 patients
Phase 2/3Unknown
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
Start: Aug 2015Est. completion: Apr 201636 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.